BioCryst Pharmaceuticals Inc.

10/10/2024 | Press release | Distributed by Public on 10/10/2024 05:12

BioCryst to Present New Real World Evidence on Long Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.